DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

7.20 0.46 (6.82%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACHN $7.20 6.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.60
Previous Close $6.74
Daily Range $6.56 - $7.24
52-Week Range $6.41 - $16.87
Market Cap $982.0M
P/E Ratio -8.53
Dividend (Yield) $0.00 (0.0%)
Volume 2,415,062
Average Daily Volume 2,965,508
Current FY EPS -$0.38




Drug Makers


A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website:

News & Commentary

Is Gilead Sciences' Dominance in Hepatitis C Unstoppable?

Four new late-stage studies from Gilead Sciences demonstrate that it's once again raised the bar in treating hepatitis C. Can anything stop Gilead?

Introduction To Dr De's Real-Time Biotech Stock Trade Alert Service

Achillion Pharmaceuticals (ACHN) Highlighted As Today's Perilous Reversal Stock

Premarket Biotech Digest: Jardiance Data, Eli Lilly Rallies, Regenxbio's Strong Debut

Gilead Provides An Update: Review And Analysis Of Wednesday's Q&A

Achillion Pharma Rises on Solid Interim Results

Can Achillion Pharmaceuticals (ACHN) Run Higher on Strong Earnings Estimate Revisions?

Does Achillion's 13% Slump in August Make It a Bargain?

Achillion is now valued at less than the potential milestones it may receive from Johnson & Johnson.

UBS: Biotech Will Continue To Outperform In 2015

Morning Market Gainers

See More ACHN News...

ACHN's Top Competitors

ACHN $7.20 (6.82%)
Current stock: ACHN
AMGN $142.47 (1.60%)
Current stock: AMGN
GILD $98.28 (0.01%)
Current stock: GILD
BIIB $290.35 (1.06%)
Current stock: BIIB